Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Major Biotechs See Rising Tide of Short Interest

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, January 12. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018

Get ready for more mergers and acquisitions in biotech and in emerging pharmaceuticals in 2018. This theme is believed by many investors, and now Credit Suisse is touting that tax ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, December 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

Stocks have risen in the first two trading days of 2018 to all-time highs, and Thursday's opening bell was indicated higher as well. The Dow has a path to rise ...
Read Full Story »

30 Big Biotech Events Coming in 2018

Over the past year, biotech companies have more or less kept pace with the markets, but they have the potential to break out in 2018. While they have been the ...
Read Full Story »

Major Biotechs See Surge in Short Interest

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

RBC Out With Top Pick Biotech Stocks to Buy for 2018

During the election battle, and for a while after, the health care stocks, including biotechnology and big pharmaceutical, were constantly buffeted by threats over drug pricing and other potential changes ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altria, Apple, GM, Procter & Gamble, Walmart and More

Stocks hit another all-time high on Monday, and the market has now put in 70 or more trading days with new highs in 2017 alone. The bull market is now nearing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Amazon, Capital One, Costco, Delphi, Twitter and Many More

Stocks were already at all-time highs going into the tax reform deal, but Monday's gains had the Dow Jones Industrial Average up over 100 points and the S&P 500 up ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Will Alexion Pharmaceuticals Fight This Activist?

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock. ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Chase Biotechs Higher

The short interest data are out for the most recent settlement date, October 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »